Qing Chang, Liang Chang, Mo Li, Liwen Fan, Shunchao Bao, Xinyu Wang, Linlin Liu: Nanobiotherapeutic strategies to target immune microenvironment of triple-negative breast cancer. Am J Cancer Res 2022;12(9):4083-4102. (Full text, PDF)
Qiuhuan Zhang, Yi Tang, Guimei Hu, Zhuoer Yuan, Shengyue Zhang, Yucao Sun, De Yin, Chencheng Dong, Jiehua Zhao, Guo Wu, Xiaoliang Huang, Jianrong Yang, Yuntian Tang: Comprehensive pan-cancer analysis identifies cellular senescence as a new therapeutic target for cancer: multi-omics analysis and single-cell sequencing validation. Am J Cancer Res 2022;12(9):4103-4119. (Full text, PDF)
Zijian Zhou, Jiajin Wu, Yuanyuan Yang, Peng Gao, Lujia Wang, Zhong Wu: Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma. Am J Cancer Res 2022;12(9):4120-4139. (Full text, PDF)
Marutpong Detarya, Worachart Lert-Itthiporn, Panupong Mahalapbutr, Methus Klaewkla, Supannika Sorin, Kanlayanee Sawanyawisuth, Atit Silsirivanit, Wunchana Seubwai, Chaisiri Wongkham, Norie Araki, Sopit Wongkham: Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. Am J Cancer Res 2022;12(9):4140-4159. (Full text, PDF)
Xuyong Wei, Wentao Xie, Weiwei Yin, Mengfan Yang, Abdul Rehman Khan, Renyi Su, Wenzhi Shu, Binhua Pan, Guanghan Fan, Kun Wang, Fan Yang, Di Lu, Changbiao Li, Linhui Pan, Beini Cen, Haiyang Xie, Li Zhuang, Shusen Zheng, Xun Zeng, Wei Chen, Xiao Xu: Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry. Am J Cancer Res 2022;12(9):4160-4176. (Full text, PDF)
Ning Ma, Tianran Chen, Yingyi Zhang, Longpei Chen, Jie Li, Xiaobo Peng, Yajie Wang, Dongxun Zhou, Bin Wang: ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation. Am J Cancer Res 2022;12(9):4177-4195. (Full text, PDF)
Glaucia Maria de Mendonça Fernandes, Vilson Serafim Junior, Ana Lívia Silva Galbiatti-Dias, Leticia Antunes Muniz Ferreira, Márcia Maria Urbanin Castanhole-Nunes, Rosa Sayoko Kawasaki-Oyama, José Victor Maniglia, Erika Cristina Pavarino, Eny Maria Goloni-Bertollo: Treatment effects of the EGFR pathway drugs on head and neck cancer stem cells. Am J Cancer Res 2022;12(9):4196-4210. (Full text, PDF)
Yi-Jou Tai, Cheng-Miao Ou, Ying-Cheng Chiang, Chi-Fang Chang, Chi-An Chen, Wen-Fang Cheng: Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients. Am J Cancer Res 2022;12(9):4211-4226. (Full text, PDF)
Wanying Liu, Qingqing Cai, Tiantian Yu, Paolo Strati, Frederick B Hagemeister, Qiongli Zhai, Mingzhi Zhang, Ling Li, Xiaosheng Fang, Jianyong Li, Ruifang Sun, Shanxiang Zhang, Hanjin Yang, Zhaoming Wang, Wenbian Qian, Noriko Iwaki, Yasuharu Sato, Eric Oksenhendler, Zijun Y Xu-Monette, Ken H Young, Li Yu: Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up. Am J Cancer Res 2022;12(9):4227-4240. (Full text, PDF)
Ikki Takada, Teruo Miyazaki, Yushi Goto, Hiroya Kanzawa, Taisuke Matsubara, Haruka Namikawa-Kanai, Shunsuke Shigefuku, Shotaro Ono, Eiji Nakajima, Yukio Morishita, Akira Honda, Kinya Furukawa, Norihiko Ikeda: Involvement of 27-hydroxycholesterol on the progression of non-small cell lung cancer via the estrogen receptor. Am J Cancer Res 2022;12(9):4241-4253. (Full text, PDF)
Sai Ge, Duo Cheng, Xuhui Zhang, Ting Xu, Zhenghang Wang, Fengxiao Dong, Lan Su, Jinlei Song, Jia Wang, Jian Li, Lin Shen, Xicheng Wang: Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients. Am J Cancer Res 2022;12(9):4254-4266. (Full text, PDF, Supplementary Tables 1, 2, 3)
Yen-Yang Chen, Shun-Wen Hsueh, Shih-Hung Yang, Sz-Chi Chiu, Nai-Jung Chiang, Tai-Jan Chiu, Chung-Pin Li, Li-Yuan Bai, Chang-Fang Chiu, Shih-Chang Chuang, Yan-Shen Shan, De-Chuan Chan, Li-Tzong Chen, Chia-Jui Yen, Cheng-Ming Peng, Jen-Shi Chen, Wen-Chi Chou: Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. Am J Cancer Res 2022;12(9):4267-4278. (Full text, PDF)
Peng Tie, Ji Cheng, Miao-Xin Xue, Jian Yin, Guo Fu, Wan-Li Duan: SLC18A3 promoted renal cancer development through acetylcholine/cAMP signaling. Am J Cancer Res 2022;12(9):4279-4289. (Full text, PDF)
Shuncong Wang, Yuanbo Feng, Lei Chen, Jie Yu, Chantal Van Ongeval, Guy Bormans, Yue Li, Yicheng Ni: Towards updated understanding of brain metastasis. Am J Cancer Res 2022;12(9):4290-4311. (Full text, PDF)
Feng Xiao, Jie Shen, Lihui Zhou, Zebin Fang, Yuxiang Weng, Chao Zhang, Luyuan Zhang, Xin Huang, Renya Zhan: ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma. Am J Cancer Res 2022;12(9):4312-4325. (Full text, PDF)
Soyeon Ko, Kyung Hee Jung, Young-Chan Yoon, Beom Seok Han, Min Seok Park, Yun Ji Lee, Sang Eun Kim, Ye Jin Cho, Pureunchowon Lee, Joo Han Lim, Ji-Kan Ryu, Kewon Kim, Tae Young Kim, Sungwoo Hong, So Ha Lee, Soon-Sun Hong: A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer. Am J Cancer Res 2022;12(9):4326-4342. (Full text, PDF)
Zongwen Wang, Qiankun Zhu, Xiaodong Li, Xiaohang Ren, Jingtao Li, Yao Zhang, Shicong Zeng, Lishan Xu, Xiaoqun Dong, Bo Zhai: TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib. Am J Cancer Res 2022;12(9):4343-4360. (Full text, PDF)
Jinguo Xia, Chen Wu, Yanhui Tang, Junwei Tang, Deming Zhu, Feihong Zhang, Zhenggang Xu, Dongwei Sun, Zhongming Tan, Han Zhuo: CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner. Am J Cancer Res 2022;12(9):4361-4372. (Full text, PDF)
Madhuri Jayathirtha, Anca-Narcisa Neagu, Danielle Whitham, Shelby Alwine, Costel C Darie: Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer. Am J Cancer Res 2022;12(9):4373-4398. (Full text, PDF)
Chiao-En Wu, Chiao-Ping Chen, Yi-Ru Pan, Shih-Ming Jung, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, John Lunec: In vitro and in vivo study of GSK2830371 and RG7388 combination in liver adenocarcinoma. Am J Cancer Res 2022;12(9):4399-4410. (Full text, PDF)
Marika Musielak, Oliwia Piwocka, Katarzyna Kulcenty, Karolina Ampu?: Biological heterogeneity of primary cancer-associated fibroblasts determines the breast cancer microenvironment. Am J Cancer Res 2022;12(9):4411-4427. (Full text, PDF)
Sheng Liu, Xinghua Cao, Shaobin Wu: High expression of SMARCC1 predicts poor prognosis in gastric cancer patients. Am J Cancer Res 2022;12(9):4428-4438. (Full text, PDF)
Shaobo Chen, Xianming Hou, Surong Hua, Ziwen Liu, Binglu Li, Xiaoyi Li, Lin Cong, Quan Liao, Jugao Fang, Lizhen Hou, Shanghua Jing, Zhen Zhao, Jianwu Qin, Songtao Zhang, Zhendong Li, Dongning Huang, Ning Zhang, Yongfu Zhao, Jun Liu, Shujun Wang, Ge Chen, Yupei Zhao: Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: a randomized clinical trial. Am J Cancer Res 2022;12(9):4439-4447. (Full text, PDF)
Xiaoning Guo, Xiaohui Wang, Sui Shen, Bryan Oronsky, Tony R Reid, Meaghan Stirn, Scott Caroen, Franck Brinkhaus, Nacer A Abrouk, Liandai Yang, Lianzong Wu, Zhongwen Yu: Subset analysis of safety and efficacy in asian patients treated with RRx-001 across three clinical trials. Am J Cancer Res 2022;12(9):4448-4457. (Full text, PDF)
Ling Han, Yali Chen, Yana Liu, Ai Zheng, Hengxi Chen: Clinical outcome of lymphadenectomy in malignant ovarian germ cell tumors: a systematic review and meta-analysis. Am J Cancer Res 2022;12(9):4458-4467. (Full text, PDF)
